Driehaus Capital Management LLC 13D and 13G filings for DICE Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-11-10 09:23 am Sale | 2022-10-31 | 13G | DICE Therapeutics, Inc. DICE | Driehaus Capital Management LLC | 1,915,496 4.020% | -231,146 (-10.77%) | Filing |
| 2022-02-14 09:24 am Purchase | 2021-12-31 | 13G | DICE Therapeutics, Inc. DICE | Driehaus Capital Management LLC | 2,146,642 5.610% | 2,146,642 (New Position) | Filing |